US3070513A - Process of splitting steroids - Google Patents

Process of splitting steroids Download PDF

Info

Publication number
US3070513A
US3070513A US29579A US2957960A US3070513A US 3070513 A US3070513 A US 3070513A US 29579 A US29579 A US 29579A US 2957960 A US2957960 A US 2957960A US 3070513 A US3070513 A US 3070513A
Authority
US
United States
Prior art keywords
splitting
enzyme
compounds
cholesterol
molecular weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29579A
Inventor
Jr Harry A Toulmin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basic Research Corp
Original Assignee
Basic Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basic Research Corp filed Critical Basic Research Corp
Priority to US29579A priority Critical patent/US3070513A/en
Application granted granted Critical
Publication of US3070513A publication Critical patent/US3070513A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • Y10S435/92Aspergillus wenti

Definitions

  • This invention relates to enzymatic processes for the splitting and destroying of steroids, sterols, lipins and the like complex polycyclic compounds containing 25 or more carbon atoms in the molecule.
  • the process of the invention is exemplified in the splitting and destruction of sterols such as cholesterol and solid fatty alcohol derivatives of cyclopententenes, phenanthrene, and the like, which are relatively stable substances and diflicult to degrade or hydrolyze.
  • sterols such as cholesterol can be oxidized with strong dichromate-sulfuric solutions to form the corresponding lower molecular weight ketones as reported by Leobisch, Doree and Diels. (See Ber. 5, 510
  • Enzymatic splitting processes for producing fatty acids and glycerol from fats, e.g., fatty acid triglycerides in the manufacture of soaps are also well known. Enzymes also have been found which are useful for splitting acyl amino acids. For example, benzoyl amino propionic acid has been reported to be split by the action of hippuricase enzyme to give benzoic acid (Neuberg and K. Linhardt, Biochemical Zeitschr. 147: 372476 (1924). Fatty acid glycerides and amino compounds, however, are relatively easily degraded, but such processes cannot be used successfully to split :a sterol such as cholesterol which has been found to remain unchanged after boiling in aqueous potassium hydroxide solution for hours.
  • prior art processes thus fail to provide a method of splitting and destroying these poly-ring steroid-type compounds by enzymatic catalysis.
  • prior processes are applicable only to in vitro-methods whereas the enzymatic process of this invention may be employed for splitting and destroying sterols in vitro or in vivo treatment methods.
  • organic solvents which dissolve these sterols, e.g., choles terol, but such compounds are more or less toxic and furthermore do not eliminate the sterols but merely put them in solution.
  • steroids e.g., cholesteryl acetate, and sterols, especially cholesterol, ergosterol, lanosterol, stigmasterol and the like poly-ring compounds of the monohydroxy secondary alcohol type which are difficult to split into lower acyclic chain compounds.
  • Cholesterol is probably best known of the sterols. This 3,970,513 Patented Dec. 25, 1962 is because it has been found to be the predominant constituent of human gall stones deposited in the bile duct. It has the empirical formula C H OH and in crystalline form melts at C.
  • the enzymatic action or degradation is carried out concurrently using a suitable combination of the enzymes to obtain a synergistic enzymatic action.
  • the reaction may, be carried out as coordinated steps whereby the sterol compound is subjected to the concentrated enzymatic action to break the cycle-ring structure followed by further enzymatic treatment to split the hydrocarbon chain structure resulting in the production of degraded, lower molecular weight compounds and ultimately openchain or acyclic organic compounds.
  • a powerful enzyme capable of attacking the cyclostructure of sterols and splitting the same is an enzyme derived from Aspergillus wentii.
  • the preparation of a suitable enzyme from the mold Aspergillus wenlii is described in the US. patent of Carlson et al., No. 2,709,150.
  • the method as therein disclosed comprises growth of the mold and production of the enzyme in the presence of a nutrient medium whose active ingredients may comprise a combination of peptone and a nutrient salt medium.
  • a typical nutrient medium which causes the mold to grow rapidly within a few days to produce a solution rich in dextranase enzymes is as follows.
  • Additional examples include: (1) a medium of the composition given above, with B-vitamins omitted; (2) a medium with the composition given above, but with the B-vitamins replaced by yeast extract, 0.4 gm. per liter; (3) a medium of the composition given above, but with the peptone replaced by casein hydrolysate 5.0 gm. per liter, either with or without the B-vitamins; (4) a medium of the composition given in which the dextran component is varied from 5.0 to 50.0 gm. per liter.
  • the inorganic salts are dissolved in the Water and sterilized by heating and then after adding the other components the pH of the medium is adjusted to between 7.2 and 7.6 by the addition of a sterile solution l-N sodium hydroxide solution.
  • a sterile solution l-N sodium hydroxide solution Use of peptone or casein hydrolyzate together with dextran salt solutions results in enhanced stimulation of the endo-dextranase from the Aspergillus wentii mold.
  • Enzyme B To provide an enzyme which vigorously attacks the Components: Grams/ liter KH PO 0.5 (NHQ SQ; 0.5 MgSO.; 0.2 CaCl 0.01 FeSO .7H O 0.005 MnSO 0.002 Na MoO .2H O 0.002 Na CO 0.1
  • the inorganic salts are dissolved in the water and the solution sterilized by treating and then the medium is adjusted to a pH of between 7.2 and 7.6 by the addition of l-N sodium hydroxide solution.
  • concentrations of the enzymes of 5 to by weight of the mass or solution are preferably employed to treat the sterols.
  • the invention will be more clearly understood from the following examples which exemplify the splitting action of the enzymes.
  • EXAMPLE I To a 10% sterile solution of cholesterol dissolved in benzene is added a portion of the medium obtained from the growth of Aspergilius wentii prepared as described under Enzyme A. Approximately 10 cc. of the clear filtrate is added to 100 cc. of the cholesterol solution and incubated for six hours at 27 C. Thereafter the reaction solution is filtered and to the filtrate containing partially degraded cholesterol there is introduced 5% by volume of the culture medium containing Agrobacterium etlumicm, and prepared as described in Example B. The enzymatic catalysis is continued at 30 C. for another six hours to complete the degradation of cholesterol to acylic compounds including beta-hydroxy-beta-methyl-glutaric acid.
  • EXAMPLE II The enzymatic catalysis is repeated as set forth in Example I, but using ergosterol to produce acyclic degraded products thereof.
  • EXAMPLE III The enzymatic catalysis in accordance with Example I is repeated using squalene to produce levulinic acid, succinic acid and acetone.
  • EXAMPLE IV EXAMPLE V
  • lanosterol is substituted for cholesterol 6 and the enzymatic catalysis carried out in situ employing the combination of Aspergillus wentii and Agrobacterium ethanicus, as described in Example IV. Degradation of the lanosterol to C C and C acyclic compounds is thus efiected.
  • Example IV was repeated using cholestryl acetate in place of cholesterol to produce lower molecular weight short-chain aliphatic compounds.
  • the enzyme may be added as a solid, dry stable form by precipitaton of the enzyme from the culture medium. This may be accomplished by adding sodium carboxymethyl cellulose (CMC) dissolved in ethyl alcohol (40 gms. CMC per 100 gms. alcohol). The CMC and enzyme precipitate is allowed to settle, and the supernatant liquor is drawn off and the solids which contain the enzyme is filtered out and after washing with ethyl alcohol dried in vacuum at about 30 C. to obtain a dry powder comprising the enzyme.
  • CMC carboxymethyl cellulose
  • the degree of splitting and destruction of the steroid or sterol is determined principally by the enzymes employed and length of time they are allowed to act on the substance to be split.
  • the pH of the enzyme-containing reaction mixture is also a factor and in general should be maintained on the alkaline side, and between 7.2 and 9.0 pH, at pH of 7.8 being preferred to speed up the catalysis action.
  • the concentration of th enzyme is not critical so long as sufficient amount is present to bring about the splitting action. An enzyme concentration of one part in one thousand on weight of sterol treated is effective but somewhat higher concentrations are preferred to accelerate the catalysis.
  • a process of splitting and destroying steroids selected from the group consisting of cholesterol, ergosterol and lanosterol into lower molecular weight compounds which consists in dissolving the steroid in solvent and reacting the same with cultures of Aspergillus wentii and Agrobacterium ethanicus which splits the ring structure of the steroid molecule into hydrocarbons of lower molecular weight, and then continuing the catalysis in the presence of an enzyme which splits the lower hydrocarbons into acyclic hydrocarbons.
  • a process of splitting and destroying cholesterol into lower molecular weight compounds which consists in dissolving the cholesterol in solvent and reacting the same with cultures of Aspergillus wentii and Agrobacterium ethanicus which splits the ring structure of the cholesterol molecule into hydrocarbons of lower molecular weight, and then continuing the catalysis in the presence of an enzyme which splits the lower hydrocarbons into acyclic hydrocarbons.
  • a process of splitting and destroying ergosterol to produce acyclic degraded compounds therefrom which comprises dissolving ergosterol in solvent and reacting the said ergosterol with a culture of Aspergillus wentzi, and continuing the catalysis in the presence of a culture of Agrobacterium ethanicus to bring about splitting of the ergosterol into lower molecular weight acyclic com pounds.
  • a process of splitting and destroying lanosterol into lower molecular weight compounds which comprises dissolving lanosterol in hydrocarbon solvent and thereafter introducing cultures of Aspergillus wentii and Agrobacterium eI/Icmicus and heating the resultant mixture for several hours at a temperature of 28 C. to effect the splitting and destroying action and produce lower acyclic hydrocarbon compounds.
  • a process of splitting and destroying lauosterol which comprises dissolving lanosterol in hydrocarbon solvent and then first treating the same with a culture of References Cited in the file of this patent UNITED STATES PATENTS Taggart Mar. 19, 1946 Carlson et a1. May 24, 1955

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)

Description

3,070,513 PROCESS OF SPLITTING STEROIDS Harry A. Toulmin, Jr., Dayton, Ohio, assignor to Basic Research Corporation, Dayton, Ohio No Drawing. Filed May 17, 1960, Ser. No. 29,579 Claims. (Cl. 195-51) This invention relates to enzymatic processes for the splitting and destroying of steroids, sterols, lipins and the like complex polycyclic compounds containing 25 or more carbon atoms in the molecule. The process of the invention is exemplified in the splitting and destruction of sterols such as cholesterol and solid fatty alcohol derivatives of cyclopententenes, phenanthrene, and the like, which are relatively stable substances and diflicult to degrade or hydrolyze.
While it is known that sterols are converted to their simple elements by microorganisms present in soils, little is known of the degrading microorganisms responsible for this action or the full nature of the reaction which takes place.
It is also known that sterols such as cholesterol can be oxidized with strong dichromate-sulfuric solutions to form the corresponding lower molecular weight ketones as reported by Leobisch, Doree and Diels. (See Ber. 5, 510
(1872); Soc. 1328 (1908); C. Doree ibid, 95, 639 (1909), v
and Ber. 41, 2596 (1908).) Further, Windaus and Resau, Ber. 46, 1246 (1913), found that the oxidation of cholesteryl acetate in boiling acetic acid and chromic acid produced methyl isohexyl ketone. Such processes have the disadvantage, however, that corrosive acids are required and it is difficult to control the action to produce the desired lower molecular weight'compounds.
Enzymatic splitting processes for producing fatty acids and glycerol from fats, e.g., fatty acid triglycerides in the manufacture of soaps are also well known. Enzymes also have been found which are useful for splitting acyl amino acids. For example, benzoyl amino propionic acid has been reported to be split by the action of hippuricase enzyme to give benzoic acid (Neuberg and K. Linhardt, Biochemical Zeitschr. 147: 372476 (1924). Fatty acid glycerides and amino compounds, however, are relatively easily degraded, but such processes cannot be used successfully to split :a sterol such as cholesterol which has been found to remain unchanged after boiling in aqueous potassium hydroxide solution for hours.
The prior art processes thus fail to provide a method of splitting and destroying these poly-ring steroid-type compounds by enzymatic catalysis. Moreover, prior processes are applicable only to in vitro-methods whereas the enzymatic process of this invention may be employed for splitting and destroying sterols in vitro or in vivo treatment methods. More recently, it has been proposed to utilize organic solvents which dissolve these sterols, e.g., choles terol, but such compounds are more or less toxic and furthermore do not eliminate the sterols but merely put them in solution.
It is the principal object of the present invention to provide a process for splitting and completely destroying steroids, e.g., cholesteryl acetate, and sterols, especially cholesterol, ergosterol, lanosterol, stigmasterol and the like poly-ring compounds of the monohydroxy secondary alcohol type which are difficult to split into lower acyclic chain compounds.
It is a further object of the invention to provide an improved process of splitting these complex compounds by treatment of the same to a powerful enzymatic action which splits open the ring structure and breaks up the compound into lower molecular weight acyclic components.
Cholesterol is probably best known of the sterols. This 3,970,513 Patented Dec. 25, 1962 is because it has been found to be the predominant constituent of human gall stones deposited in the bile duct. It has the empirical formula C H OH and in crystalline form melts at C.
The structural molecular configurations of cholesterol as well as ergosterol, lanosterol and stigmasterol are shown in the formulae:
H C CH CH CH CH CH Tl- CH 3 CHOLESTEROL CH Hgc 3 ERGOSTEROL LANOSTEROL Stigmasterol e a; In accordance with the present invention, a new enzy- EXAMPLE A steroid ENZYM ATIC CATALY$lS degradation pro due to ACYCLIC COMPOUNDS EXAMPLE B sterols \(VY Enzymatic catalysis acyoli 0 compounds In view of the high specificity of enzymes, it is essential to employ the proper enzyme or combination of enzymes to carry out the treatment under conditions which produce the powerful splitting action required to degrade the complex cyclo organic compounds. To accomplish this two types of enzymes are employed, one which breaks or splits the cycle-ring structure and another which attacks and splits the hydrocarbon chain structure. Preferably the enzymatic action or degradation is carried out concurrently using a suitable combination of the enzymes to obtain a synergistic enzymatic action. The reaction, however, may, be carried out as coordinated steps whereby the sterol compound is subjected to the concentrated enzymatic action to break the cycle-ring structure followed by further enzymatic treatment to split the hydrocarbon chain structure resulting in the production of degraded, lower molecular weight compounds and ultimately openchain or acyclic organic compounds.
A powerful enzyme capable of attacking the cyclostructure of sterols and splitting the same is an enzyme derived from Aspergillus wentii.
The preparation of a suitable enzyme from the mold Aspergillus wenlii is described in the US. patent of Carlson et al., No. 2,709,150. The method as therein disclosed comprises growth of the mold and production of the enzyme in the presence of a nutrient medium whose active ingredients may comprise a combination of peptone and a nutrient salt medium.
A typical nutrient medium which causes the mold to grow rapidly within a few days to produce a solution rich in dextranase enzymes is as follows.
Distilled water, 1 liter.
Additional examples include: (1) a medium of the composition given above, with B-vitamins omitted; (2) a medium with the composition given above, but with the B-vitamins replaced by yeast extract, 0.4 gm. per liter; (3) a medium of the composition given above, but with the peptone replaced by casein hydrolysate 5.0 gm. per liter, either with or without the B-vitamins; (4) a medium of the composition given in which the dextran component is varied from 5.0 to 50.0 gm. per liter. In preparation of the enzyme-containing medium the inorganic salts are dissolved in the Water and sterilized by heating and then after adding the other components the pH of the medium is adjusted to between 7.2 and 7.6 by the addition of a sterile solution l-N sodium hydroxide solution. Use of peptone or casein hydrolyzate together with dextran salt solutions results in enhanced stimulation of the endo-dextranase from the Aspergillus wentii mold.
Enzyme B To provide an enzyme which vigorously attacks the Components: Grams/ liter KH PO 0.5 (NHQ SQ; 0.5 MgSO.; 0.2 CaCl 0.01 FeSO .7H O 0.005 MnSO 0.002 Na MoO .2H O 0.002 Na CO 0.1
Distilled water, 1 liter.
In preparation of the medium, the inorganic salts are dissolved in the water and the solution sterilized by treating and then the medium is adjusted to a pH of between 7.2 and 7.6 by the addition of l-N sodium hydroxide solution.
In carrying out the splitting action of the invention concentrations of the enzymes of 5 to by weight of the mass or solution are preferably employed to treat the sterols. The invention will be more clearly understood from the following examples which exemplify the splitting action of the enzymes.
EXAMPLE I To a 10% sterile solution of cholesterol dissolved in benzene is added a portion of the medium obtained from the growth of Aspergilius wentii prepared as described under Enzyme A. Approximately 10 cc. of the clear filtrate is added to 100 cc. of the cholesterol solution and incubated for six hours at 27 C. Thereafter the reaction solution is filtered and to the filtrate containing partially degraded cholesterol there is introduced 5% by volume of the culture medium containing Agrobacterium etlumicm, and prepared as described in Example B. The enzymatic catalysis is continued at 30 C. for another six hours to complete the degradation of cholesterol to acylic compounds including beta-hydroxy-beta-methyl-glutaric acid.
EXAMPLE II The enzymatic catalysis is repeated as set forth in Example I, but using ergosterol to produce acyclic degraded products thereof.
EXAMPLE III The enzymatic catalysis in accordance with Example I is repeated using squalene to produce levulinic acid, succinic acid and acetone.
EXAMPLE IV EXAMPLE V In this instance lanosterol is substituted for cholesterol 6 and the enzymatic catalysis carried out in situ employing the combination of Aspergillus wentii and Agrobacterium ethanicus, as described in Example IV. Degradation of the lanosterol to C C and C acyclic compounds is thus efiected. v
EXAMPLE VI In this instance stigmasterol was split to produce lower molecular weight acyclic components when treated as described in Example I.
EXAMPLE VII Example IV was repeated using cholestryl acetate in place of cholesterol to produce lower molecular weight short-chain aliphatic compounds.
In place of employing the enzyme culture mediums as described, the enzyme may be added as a solid, dry stable form by precipitaton of the enzyme from the culture medium. This may be accomplished by adding sodium carboxymethyl cellulose (CMC) dissolved in ethyl alcohol (40 gms. CMC per 100 gms. alcohol). The CMC and enzyme precipitate is allowed to settle, and the supernatant liquor is drawn off and the solids which contain the enzyme is filtered out and after washing with ethyl alcohol dried in vacuum at about 30 C. to obtain a dry powder comprising the enzyme.
In the enzymatic catalysis action the degree of splitting and destruction of the steroid or sterol is determined principally by the enzymes employed and length of time they are allowed to act on the substance to be split. The pH of the enzyme-containing reaction mixture is also a factor and in general should be maintained on the alkaline side, and between 7.2 and 9.0 pH, at pH of 7.8 being preferred to speed up the catalysis action. The concentration of th enzyme is not critical so long as sufficient amount is present to bring about the splitting action. An enzyme concentration of one part in one thousand on weight of sterol treated is effective but somewhat higher concentrations are preferred to accelerate the catalysis.
Various substitutions and changes may be made in the process by those skilled in the art without departing from the spirit and scope of the invention.
What is claimed is:
1. A process of splitting and destroying steroids selected from the group consisting of cholesterol, ergosterol and lanosterol into lower molecular weight compounds which consists in dissolving the steroid in solvent and reacting the same with cultures of Aspergillus wentii and Agrobacterium ethanicus which splits the ring structure of the steroid molecule into hydrocarbons of lower molecular weight, and then continuing the catalysis in the presence of an enzyme which splits the lower hydrocarbons into acyclic hydrocarbons.
2. A process of splitting and destroying cholesterol into lower molecular weight compounds which consists in dissolving the cholesterol in solvent and reacting the same with cultures of Aspergillus wentii and Agrobacterium ethanicus which splits the ring structure of the cholesterol molecule into hydrocarbons of lower molecular weight, and then continuing the catalysis in the presence of an enzyme which splits the lower hydrocarbons into acyclic hydrocarbons.
3. A process of splitting and destroying ergosterol to produce acyclic degraded compounds therefrom which comprises dissolving ergosterol in solvent and reacting the said ergosterol with a culture of Aspergillus wentzi, and continuing the catalysis in the presence of a culture of Agrobacterium ethanicus to bring about splitting of the ergosterol into lower molecular weight acyclic com pounds.
4. A process of splitting and destroying lanosterol into lower molecular weight compounds which comprises dissolving lanosterol in hydrocarbon solvent and thereafter introducing cultures of Aspergillus wentii and Agrobacterium eI/Icmicus and heating the resultant mixture for several hours at a temperature of 28 C. to effect the splitting and destroying action and produce lower acyclic hydrocarbon compounds.
5. A process of splitting and destroying lauosterol which comprises dissolving lanosterol in hydrocarbon solvent and then first treating the same with a culture of References Cited in the file of this patent UNITED STATES PATENTS Taggart Mar. 19, 1946 Carlson et a1. May 24, 1955

Claims (1)

1. A PROCESS OF SPLITTING AND DESTROYING STEROIDS SELECTED FROM THE GROUP CONSISTING OF CHOLESTEROL, ERGOSTEROL AND LANOSTEROL INTO LOWER MOLECULAR WEIGHT COMPOUNDS WHICH CONSISTS IN DISSOLVING THE STEROID IN SOLVENT AND REACITNG THE SAME WITH CULTURES OF ASPERGILLUS WENTII AND AGROBACTERIUM EHTANICUS WHICH SPLITS THE RING STRUCTURE OF THE STEROID MOLECULE INTO HYDROCARBONS OF LOWER MOLECULAR WEIGHT, AND THEN CONTINUING THE CATALYSIS IN THE PRESENCE OF AN ENZYME WHICH SPLITS THE LOWER HYDROCARBONS INTO ACYCLIC HYDROCARBONS.
US29579A 1960-05-17 1960-05-17 Process of splitting steroids Expired - Lifetime US3070513A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29579A US3070513A (en) 1960-05-17 1960-05-17 Process of splitting steroids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29579A US3070513A (en) 1960-05-17 1960-05-17 Process of splitting steroids

Publications (1)

Publication Number Publication Date
US3070513A true US3070513A (en) 1962-12-25

Family

ID=21849776

Family Applications (1)

Application Number Title Priority Date Filing Date
US29579A Expired - Lifetime US3070513A (en) 1960-05-17 1960-05-17 Process of splitting steroids

Country Status (1)

Country Link
US (1) US3070513A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2396900A (en) * 1942-03-09 1946-03-19 Standard Oil Dev Co Utilization of hydrocarbons
US2709150A (en) * 1951-08-09 1955-05-24 Enzmatic Chemicals Inc Method of producing dextran material by bacteriological and enzymatic action

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2396900A (en) * 1942-03-09 1946-03-19 Standard Oil Dev Co Utilization of hydrocarbons
US2709150A (en) * 1951-08-09 1955-05-24 Enzmatic Chemicals Inc Method of producing dextran material by bacteriological and enzymatic action

Similar Documents

Publication Publication Date Title
US2649402A (en) Steroids
US2695260A (en) Process for the oxygenation of steroids with the oxygenating activity of neurospora
US2649400A (en) Steroids
US3530038A (en) Process for preparation of trihydroxy steroids
GB2123833A (en) Steroid 1,2-dehydrogenation using dried microbial cells
US3070513A (en) Process of splitting steroids
US3070512A (en) Process of splititing steroids
JPS6130552B2 (en)
US2960436A (en) Synthesis of steroids by diplodia natalensis
PL103989B1 (en) HOW TO MAKE NEW 7 ALPHA-SUBSTITUTED ESTRADIOLS
US3360439A (en) Process for preparing 1-dehydro steroids
US2889255A (en) 15-hydroxylation of steroids by gibberella and fusarium
US3112249A (en) Process of splitting steroids
US2960513A (en) Delta4-androstene-7alpha-ol-3, 17-dione and esters thereof
US2840578A (en) 9alpha-hydroxyprogesterone
US2863806A (en) 17alpha hydroxylation of steroids by trichoderma viride
US2958631A (en) Hydroxylated steroids and methods for their manufacture using bacillus megatherium
US2762747A (en) Preparation of 17-keto steroid by penicillium
US2950226A (en) Method of producing 11alpha-hydroxysteroids with the genus fusarium
US3031477A (en) Delta4-pregene-7alpha, 17alpha, 21-triol-3, 20-dione and esters thereof
US2902498A (en) delta1,4-androstadienes
US3364237A (en) 4, 8, 14-trimethyl-9alpha-hydroxy-18-nor-8alpha, 14beta-androst-4-en-3, 11, 17-trione and derivatives thereof
US3004047A (en) 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US2992973A (en) Dehydrogenation of steroids by azotobacter microorganisms
US3236880A (en) 9alpha-halo-a-norandrost-3-ene-2, 11, 17-triones and 9alpha-halo-11-oxo or beta-hydroxy-a-nortestosterones and acylderivatives